Applied DNA Sciences Inc
NASDAQ:APDN

Watchlist Manager
Applied DNA Sciences Inc Logo
Applied DNA Sciences Inc
NASDAQ:APDN
Watchlist
Price: 5.26 USD 1.15% Market Closed
Market Cap: 2.7m USD
Section:
Relative Value
Relative Value
Valuation Multiples
Multiples Across Competitors
See Also

Relative Value

APDN doesn't have a meaningful market cap.

The Relative Value of one APDN stock under the Base Case scenario is 41.27 USD. Compared to the current market price of 5.26 USD, Applied DNA Sciences Inc is Undervalued by 87%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

APDN Relative Value
Base Case
41.27 USD
Undervaluation 87%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

0.7
P/S
P/S
Price to Sales
0.7
vs History
96
vs Industry
89
Median 3Y
441.8
Median 5Y
622
Industry
4
Forward
0.5
More Details
Negative
P/E
P/E
Price to Earnings
N/A
vs History
vs Industry
Median 3Y
-590.5
Median 5Y
-1 431
Industry
31.5
Forward
-0
More Details
Negative
P/OCF
P/OCF
Price to OCF
N/A
vs History
vs Industry
Median 3Y
-574.2
Median 5Y
-1 443.6
Industry
19.6
More Details
Negative
P/FCFE
P/FCFE
Price to FCFE
N/A
vs History
vs Industry
Median 3Y
-574.2
Median 5Y
-1 308.6
Industry
32.5
More Details
0.3
P/B
P/B
Price to Book Value
0.3
vs History
92
vs Industry
91
Median 3Y
780.1
Median 5Y
1 313.3
Industry
2.7
More Details
Negative
EV/S
EV/S
Enterprise Value to Sales
N/A
vs History
vs Industry
95
Median 3Y
441.1
Median 5Y
621.3
Industry
3.8
Forward
-0.8
More Details
Negative
EV/GP
EV/GP
Enterprise Value to Gross Profit
N/A
vs History
vs Industry
90
Median 3Y
1 286.2
Median 5Y
1 750.5
Industry
8.4
More Details
0.3
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
0.3
vs History
1
vs Industry
49
Median 3Y
-393.3
Median 5Y
-1 007.8
Industry
17.6
More Details
0.3
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
0.3
vs History
1
vs Industry
44
Median 3Y
-354.8
Median 5Y
-899.6
Industry
23.9
Forward
0.3
More Details
0.3
EV/OCF
EV/OCF
Enterprise Value to OCF
0.3
vs History
1
vs Industry
54
Median 3Y
-573.8
Median 5Y
-1 441.9
Industry
18.2
More Details
0.3
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
0.3
vs History
1
vs Industry
41
Median 3Y
-573.8
Median 5Y
-1 307
Industry
23.3
More Details
Negative
EV/IC
EV/IC
Enterprise Value to IC
N/A
vs History
vs Industry
89
Median 3Y
866.6
Median 5Y
2 099.8
Industry
2.4
More Details

Multiples Across Competitors

APDN Competitors Multiples
Applied DNA Sciences Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Applied DNA Sciences Inc
NASDAQ:APDN
2.7m USD 0.7 -0.1 0.3 0.3
US
PerkinElmer Inc
LSE:0KHE
1T USD 361.1 3 490 1 223.8 2 496.2
US
Thermo Fisher Scientific Inc
NYSE:TMO
176.2B USD 4.1 27 18.6 25.7
US
Danaher Corp
NYSE:DHR
142.1B USD 6 37.7 20.8 30.2
KR
Samsung Biologics Co Ltd
KRX:207940
71.2T KRW 14.5 55.6 32.3 44.9
CH
Lonza Group AG
SIX:LONN
39.9B CHF 6.1 62.7 23 35.8
US
Agilent Technologies Inc
NYSE:A
33.9B USD 5.1 29.1 19.7 23.2
CN
WuXi AppTec Co Ltd
SSE:603259
242.8B CNY 5.9 21.7 21.1 21.1
US
IQVIA Holdings Inc
NYSE:IQV
33.7B USD 2.2 25.2 13.2 19.7
US
Mettler-Toledo International Inc
NYSE:MTD
26.1B USD 6.8 30.7 22.8 25.3
IN
Divi's Laboratories Ltd
NSE:DIVISLAB
1.8T INR 19.2 80 58.1 67.1

See Also

Summary
APDN intrinsic value, competitors valuation, and company profile.
DCF Valuation
APDN stock valuation using Discount Cash Flow valuation method.
Relative Valuation
APDN stock valuation using valuation multiples.
Wall Street Estimates
APDN price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
APDN stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 269,800+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.